@article{10.1172/JCI163508, author = {Yu Sun AND Hadrien Demagny AND Adrien Faure AND Francesca Pontanari AND Antoine Jalil AND Nadia Bresciani AND Ece Yildiz AND Melanie Korbelius AND Alessia Perino AND Kristina Schoonjans}, journal = {The Journal of Clinical Investigation}, publisher = {The American Society for Clinical Investigation}, title = {Asparagine protects pericentral hepatocytes during acute liver injury}, year = {2023}, month = {4}, volume = {133}, url = {https://www.jci.org/articles/view/163508}, abstract = {The nonessential amino acid asparagine can only be synthesized de novo by the enzymatic activity of asparagine synthetase (ASNS). While ASNS and asparagine have been implicated in the response to numerous metabolic stressors in cultured cells, the in vivo relevance of this enzyme in stress-related pathways remains unexplored. Here, we found ASNS to be expressed in pericentral hepatocytes, a population of hepatic cells specialized in xenobiotic detoxification. ASNS expression was strongly enhanced in 2 models of acute liver injury: carbon tetrachloride (CCl4) and acetaminophen. We found that mice with hepatocyte-specific Asns deletion were more prone to pericentral liver damage than their control littermates after toxin exposure. This phenotype could be reverted by i.v. administration of asparagine. Unexpectedly, the stress-induced upregulation of ASNS involved an ATF4-independent, noncanonical pathway mediated by the nuclear receptor, liver receptor homolog 1 (LRH-1; NR5A2). Altogether, our data indicate that the induction of the asparagine-producing enzyme ASNS acts as an adaptive mechanism to constrain the necrotic wave that follows toxin administration and provide proof of concept that i.v. delivery of asparagine can dampen hepatotoxin-induced pericentral hepatocellular death.}, number = {7}, doi = {10.1172/JCI163508}, url = {https://doi.org/10.1172/JCI163508}, }